Replication-deficient recombinant adenoviruses expressing the human immunodeficiency virus Env antigen can induce both humoral and CTL immune responses In mice

Journal of General Virology

Volumn 80, Issue 10, 1999, Pages 2621-2628

  Bruce, Christine B ^a   Akrigg, Alan ^a   Sharpe, Sally A ^a   Hanke, Tomáš ^b   Wilkinson, Gavin W G ^c   Cranage, Martin P ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMORAL IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS ENVELOPE; VIRUS IMMUNITY; VIRUS RECOMBINANT;

EID: 0032862594     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-80-10-2621     Document Type: Article

References (37)

1. Arya, S. K., Guo, C., Josephs, S. F. & Wong-Staal, F. (1985). Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). Science 229, 69-73.
2. Barksdale, S. K. & Baker, C. C. (1995). The human immunodeficiency virus type 1 Rev protein and the Rev-responsive element counteract the effect of an inhibitory 5′ splice site in a 3′ untranslated region. Molecular and Cellular Biology 15, 2962-2971.
3. Chanda, P. K., Natuk, R. J., Mason, B. B., Bhat, B. M., Greenberg, L., Dheer, S. K., Molnar-Kimber, K. L., Mizutani, S., Lubeck, M. D., Davis, A. R. & Hung, P. P. (1990). High level expression of the envelope glycoproteins of the human immunodeficiency virus type I in presence of rev gene using helper-independent adenovirus type 7 recombinants. Virology 175, 535-547.
4. Chang, D. D. & Sharp, P. A. (1989). Regulation by HIV Rev depends upon recognition of splice sites. Cell 59, 789-795.
5. Chenciner, N., Randrianarison-Jewtoukoff, V., Delpeyroux, F., Hanania, N., Pedroza Martins, L., Stratford Perricaudet, L., Perricaudet, M. & Wain-Hobson, S. (1997). Enhancement of humoral immunity to SIVenv following simultaneous inoculation of mice by three recombinant adenoviruses encoding SIVenv/poliovirus chimeras, Tat and Rev. AIDS Research and Human Retroviruses 13, 801-806.
6. Dewar, R. L., Natarajan, V., Vasudevachari, M. B. & Salzman, N. P. (1989). Synthesis and processing of human immunodeficiency virus type 1 envelope proteins encoded by a recombinant human adenovirus. Journal of Virology 63, 129-136.
7. Emerman, M., Vazeux, R. & Peden, K. (1989). The rev gene product of the human immunodeficiency virus affects envelope-specific RNA localization. Cell 57, 1155-1165.
8. Feinberg, M. B., Jarrett, R. F., Aldovini, A., Gallo, R. C. & Wong-Staal, F. (1986). HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA. Cell 46, 807-817.
9. Flanagan, B., Pringle, C. R. & Leppard, K. N. (1997). A recombinant human adenovirus expressing the simian immunodeficiency virus Gag antigen can induce long-lived immune responses in mice. Journal of General Virology 78, 991-997.
10. Fooks, A. R., Schadeck, E., Liebert, U. G., Dowsett, A. B., Rima, B. K., Steward, M., Stephenson, J. R. & Wilkinson, G. W. G. (1995). High-level expression of the measles virus nucleocapsid protein by using a replication-deficient adenovirus vector: induction of an MHC-1-restricted CTL response and protection in a murine model. Virology 210, 456-465.
11. Fooks, A. R., Jeevarajah, D., Lee, J., Warnes, A., Niewiesk, S., ter Meulen, V., Stephenson, J. R. & Clegg, J. C. S. (1998). Oral or parenteral administration of replication-deficient adenoviruses expressing the measles virus haemagglutinin and fusion proteins: protective immune responses in rodents. Journal of General Virology 79, 1027-1031.
12. Graham, F. L., Smiley, J., Russell, W. C. & Nairn, R. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. Journal of General Virology 36, 59-74.
13. Hammarskjold, M.-L., Li, H., Rekosh, D. & Prasad, S. (1994). Human immunodeficiency virus env expression becomes Rev-independent if the env region is not defined as an intron. Journal of Virology 68, 951-958.
14. Hanke, T., Schneider, J., Gilbert, S. C., Hill, A. V. S. & McMichael, A. (1998a). DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice. Vaccine 16, 426-435.
15. Hanke, T., Blanchard, T. J., Schneider, J., Hannan, C. M., Becker, M., Gilbert, S. C., Hill, A. V. S., Smith, G. L. & McMichael, A. (1998b). Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime. Vaccine 16, 439-445.
16. Imler, J.-L. (1995). Adenovirus vectors as recombinant viral vaccines. Vaccine 13, 1143-1151.
17. Jacobs, S. C., Stephenson, J. R. & Wilkinson, G. W. G. (1992). High-level expression of the tick-borne encephalitis virus NS1 protein by using an adenovirus-based vector: protection elicited in a murine model. Journal of Virology 66, 2086-2095.
18. Jones, D. H., McBride, B. W., Roff, M. A. & Farrar, G. H. (1995). Efficient purification and rigorous characterisation of a recombinant gp120 for HIV vaccine studies. Vaccine 13, 991-999.
19. Juillard, V., Villefroy, P., Godfrin, D., Pavirani, A. M., Venet, A. & Guillet, J.-G. (1995). Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector. European Journal of Immunology 25, 3467-3473.
20. Kjems, J. & Sharp, P. A. (1993). The basic domain of Rev from human immunodeficiency virus type 1 specifically blocks the entry of U4/U6.U5 small nuclear ribonucleoprotein in spliceosome assembly. Journal of Virology 67, 4769-4776.
21. Lu, X. B., Heimer, J., Rekosh, D. & Hammarskjold, M.-L. (1990). U1 small nuclear RNA plays a direct role in the formation of a rev-regulated human immunodeficiency virus env mRNA that remains unspliced. Proceedings of the National Academy of Sciences, USA 87, 7598-7602.
22. Lubeck, M. D., Natuk, R. J., Chengalvala, M., Chanda, P. K., Murthy, K. K., Murthy, S., Mizutani, S., Lee, S.-G., Wade, M. S., Bhat, B. M., Bhat, R., Dheer, S. K., Eichberg, J. W., Davis, A. R. & Hung, P. P. (1994). Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration. AIDS Research and Human Retroviruses 10, 1443-1449.
23. McGrory, W. J., Bautista, D. S. & Graham, F. L. (1988). A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology 163, 614-617.
24. Mikaelian, I., Krieg, M., Gait, M. J. & Karn, J. (1996). Interactions of INS (CRS) elements and the splicing machinery regulate the production of Rev-responsive mRNAs. Journal of Molecular Biology 257, 246-264.
25. Nasioulas, G., Zolotukhin, A. S., Tabernero, C., Solomin, L., Cunningham, C. P., Pavlakis, G. N. & Felber, B. K. (1994). Elements distinct from human immunodeficiency virus type 1 splice sites are responsible for the Rev dependence of env mRNA. Journal of Virology 68, 2986-2993.
26. Natuk, R. J., Chanda, P. K., Lubeck, M. D., Davis, A. R., Wilhelm, J., Hjorth, R., Wade, M. S., Bhat, B. M., Mizutani, S., Lee, S., Eichberg, J., Gallo, R. C., Hung, P. P. & Robert-Guroff, M. (1992). Adenovirus-human immunodeficiency virus (HIV) envelope recombinant vaccines elicit high-titered HIV-neutralizing antibodies in the dog model. Proceedings of the National Academy of Sciences, USA 89, 7777-7781.
27. Natuk, R. J., Lubeck, M. D., Chanda, P. K., Chengalvala, M., Wade, M. S., Murthy, S. C. S., Wilhelm, J., Vernon, S. K., Dheer, S. K., Mizutani, S., Lee, S.-G., Murthy, K. K., Eichberg, J. G., Davis, A. R. & King, P. P. (1993). Immunogenicity of recombinant human adenovirus-human immunodeficiency virus vaccines in chimpanzees. AIDS Research and Human Retroviruses 9, 395-404.
28. mac infection. AIDS Research and Human Retroviruses 13, 923-931.
29. Ratner, L., Haseltine, W., Patarca, R., Livak, K. J., Starcich, B., Josephs, S. J., Doran, E. R., Rafalski, J. A., Whitehorn, E. A., Baumeister, K., Ivanoff, L., Petteway, S. R., Jr, Pearson, M. L., Lautenberger, J. A., Papas, T. S., Ghrayeb, J., Chang, N. T., Gallo, R. C. & Wong-Staal, F. (1985). Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 313, 277-284.
30. Rosen, C. A., Terwilliger, E., Dayton, A. I., Sodroski, J. G. & Haseltine, W. A. (1988). Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus. Proceedings of the National Academy of Sciences, USA 85, 2071-2075.
31. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
32. Sodroski, J., Goh, W. C., Rosen, C. A., Dayton, A., Terwilliger, E. & Haseltine, W. A. (1986). A second post-transcriptional trans-activator gene required for HTLV-III replication. Nature 321, 412-417.
33. + cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells. International Immunology 5, 849-857.
34. Van Beveren, C., Coffin, J. & Hughes, S. (1985). HTLV-3 genome. In RNA Tumor Viruses, 2nd edn, Supplements and Appendices, pp. 1109-1123. Edited by R. Weiss, N. Teich & J. Coffin. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
35. Wilkinson, G. W. G. (1994). Gene therapy and viral vaccination. Reviews in Medical Microbiology 5, 97-106.
36. Wilkinson, G. W. G. & Akrigg, A. (1992). Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector. Nucleic Acids Research 20, 2233-2239.
37. Zhang, W. W., Fang, X., Branch, C. D., Mazur, W., French, B. A. & Roth, J. A. (1993). Generation and identification of recombinant adenovirus by liposome-mediated transfection and PCR analysis. Biotechniques 15, 868-872.